Literature DB >> 26458717

Hyperleukocytosis, an unusual paraneoplastic manifestation of lung cancer: Case report and review of literature.

Aparna Sreevatsa1, Suresh M C Babu, Govind K Babu, T M Suresh.   

Abstract

Leukocytosis may be found in patients with lung cancer either at time of diagnosis or during the course of the disease. Though mild leukocytosis is common in lung cancer, hyperleukocytosis defined as total leukocyte count more than 100,000 is uncommon. We describe a 68-year-old chronic smoker who presented with osteolytic pelvic bone lesion and hyperleukocytosis, who on evaluation was found to have a primary lung cancer. Bone marrow aspiration and biopsy showed marked myeloid hyperplasia. Myeloid series comprised predominantly mature neutrophils and stab forms. Cytogenetic investigation showed a normal chromosome set (46, XY). Repeated cultures from blood, urine, and sputum were sterile. He was started on chemotherapy but had a progressive downhill course. In patient with lung cancer, leukocytosis can be due to infection, use of corticosteroid or hematopoetic growth factors, bone marrow involvement, or paraneoplastic manifestation. Paraneoplastic leukocytosis is associated with poor prognosis and aggressive disease.

Entities:  

Mesh:

Year:  2015        PMID: 26458717     DOI: 10.4103/0973-1482.151865

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  5 in total

Review 1.  Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report.

Authors:  Clelia Madeddu; Elisabetta Sanna; Sonia Nemolato; Olga Mulas; Sara Oppi; Mario Scartozzi; Giorgio La Nasa; Antonio Maccio
Journal:  Diagnostics (Basel)       Date:  2022-08-07

2.  [Paraneoplastic hyperleukocytosis in lung cancer].

Authors:  Josef Heusinger; Paul Czech; Heidi Hengstler; Frank Schaumann; Anja Rückert; Frank Schmid; Jörg Kalla; Uta Diergardt; Hinrich Bremer; Paul La Rosée
Journal:  Inn Med (Heidelb)       Date:  2022-09-23

3.  Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy.

Authors:  Thilo Gambichler; E Stockfleth; L Susok
Journal:  J Immunother Cancer       Date:  2018-10-30       Impact factor: 13.751

4.  A case of a 22-month-old boy with necrotizing pneumonia presenting with leukaemoid reaction misdiagnosed as leukaemia: a case report and review of the literature.

Authors:  Shakilu Jumanne; Azan Nyundo
Journal:  Malawi Med J       Date:  2019-09       Impact factor: 0.875

Review 5.  Spontaneous remission of advanced progressive poorly differentiated non-small cell lung cancer: a case report and review of literature.

Authors:  Hee-Young Yoon; Heae Surng Park; Min Sun Cho; Sung Shin Shim; Yookyung Kim; Jin Hwa Lee
Journal:  BMC Pulm Med       Date:  2019-11-11       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.